Free Trial

NKGen Biotech (NKGNW) SEC Filings & 10K Form

$0.04 -0.04 (-50.00%)
As of 06/20/2025 10:41 AM Eastern

Recent NKGen Biotech SEC Filings

DateFilerForm TypeView
06/20/2025
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
11:11 AM
CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:12 AM
CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SCHEDULE 13D
05/20/2025
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
11:29 AM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:06 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:09 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form NT 10-K
03/11/2025
8:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
12:45 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 424B3
03/04/2025
5:34 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/28/2025
4:46 PM
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
PATHSTONE FAMILY OFFICE, LLC (Filed by)
Form SCHEDULE 13G
02/25/2025
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:34 AM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SCHEDULE 13G/A
02/03/2025
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form DEF 14A
01/08/2025
4:29 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:54 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
6:20 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:23 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:55 PM
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:10 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
4:22 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:01 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:06 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
5:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:00 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:09 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:16 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:26 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
5:45 PM
CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2024
4:22 PM
CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SC 13G
A grave, grave error. (Ad)

President Donald Trump made headlines last month with a staggering claim. He stated that since taking office, more than $12 trillion in private investments into America have been “practically committed” on his watch. "Nobody's ever seen numbers like we have," he said, crediting his agenda of tariffs, tax cuts, and deregulation with making the difference. If true, the figure would indeed be astonishing – potentially tripling the roughly $4 trillion in gross private investment the US reported all of last year.

That means that you could still get in early on the biggest technological shift in history. But onl
08/22/2024
3:42 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
7:31 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form ARS
07/22/2024
4:19 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form DEF 14A
07/18/2024
4:52 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:53 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
7:15 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:58 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form PRER14A
07/12/2024
6:19 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
4:21 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 424B3
07/08/2024
11:15 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form EFFECT
06/27/2024
3:34 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NKGNW) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners